FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / ...

ABL Advisor Search Results

News Stories (54 Results) - Pharmaceuticals

Corbus Pharmaceuticals Holdings, a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, announced it has received an aggregate of $71 million in gross proceeds from its at-the-market... Read Story

July 30, 2020, 08:10 AM

Fennec Pharmaceuticals Inc., a specialty pharmaceutical company focused on the development of PEDMARK™ (a unique formulation of sodium thiosulfate) for the prevention of platinum-induced ototoxicity in pediatric patients, today announced an amendment... Read Story

June 29, 2020, 08:40 AM

MidCap Business Credit completed a $5 million revolving credit facility for Appco Pharma, LLC.  The facility was used to provide additional liquidity and support the company’s growth plans and working capital needs.Appco is a privately owned and... Read Story

March 04, 2020, 09:10 AM

In an attempt to gain a foothold in the cash-laden tech industry, some biotechnology and pharmaceutical companies have begun snapping up choice digital health companies, with a few billion-dollar deals leading the trend.Digital health deal values in... Read Story

December 13, 2019, 09:00 AM

Rigel Pharmaceuticals, Inc. announced that it has entered into a $60 million term loan credit facility with MidCap Financial (MidCap). At closing, $10 million was funded to Rigel in an initial tranche. The facility also gives Rigel the ability to... Read Story

October 02, 2019, 09:00 AM

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported that it has entered into a note purchase agreement for up to $150 million of senior secured notes with funds managed... Read Story

September 16, 2019, 08:00 AM

ObsEva SA, a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy, announced the closing of a $75... Read Story

August 07, 2019, 08:00 AM

Antares Pharma, Inc. announced that it has entered into an amendment to its existing loan and security agreement with Hercules Capital, Inc. (HTGC), to increase the available debt capital by $25 million for a term loan of up to $50 million. The... Read Story

July 15, 2019, 09:00 AM

MidCap Business Credit completed an $8 million Revolving Credit Facility for Sovereign Pharmaceuticals, LLC.  The facility was used to refinance the company’s existing senior debt and to support the company’s growth plans and working capital... Read Story

January 02, 2019, 09:00 AM

Nevakar Inc., a specialty pharmaceutical company developing multiple differentiated products in the ophthalmic and injectable areas, announced that it has entered into a $20 million senior secured term loan with Oxford Finance LLC. As part of the... Read Story

December 03, 2018, 08:00 AM

Monroe Capital LLC announced an increase in its credit facility to ProPharma Group (ProPharma) to support the acquisition of Xendo Holding B.V. (Xendo). ProPharma is an existing portfolio company of Linden Capital Partners. Based in the Netherlands... Read Story

August 21, 2018, 08:00 AM

Capitala Group, a provider of capital to lower and traditional middle market companies, announced that it recently originated a combination of a senior secured debt facility and minority equity totaling $27.3 million to support Cold Bore Capital in... Read Story

July 24, 2018, 07:00 AM

XOMA Corporation, a pioneer in the discovery, development and licensing of therapeutic antibodies, announced it has entered into a flexible $20 million credit facility with Silicon Valley Bank, with availability through March 2019.“This credit... Read Story

May 08, 2018, 08:01 AM

Tricida, Inc., a South San Francisco, CA-based late-stage pharmaceutical company, entered into a $100 million venture debt facility with Hercules Capital, Inc. Tricida drew down $25 million from the venture debt facility at closing. An additional... Read Story

March 06, 2018, 07:00 AM

Molecular Templates, a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, announced the... Read Story

March 05, 2018, 06:00 AM

Verastem, Inc., focused on discovering and developing drugs to improve the survival and quality of life of cancer patients, announced its entry into an amendment to its Loan and Security Agreement with Hercules Capital, Inc., increasing its existing... Read Story

January 05, 2018, 07:15 AM

Midatech, the international specialty pharmaceutical company focused on developing and commercializing products in oncology, announced that it has entered into a four-year senior secured loan agreement with MidCap Financial of up to $15... Read Story

January 02, 2018, 07:00 AM

Nuvo Pharmaceuticals Inc., a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, announced that it has secured a $6.0 million operating revolving credit facility with Royal Bank of... Read Story

August 25, 2017, 08:00 AM

Presidential Financial Corporation announced it has provided a $15 million working capital facility to Unicare Pharmacy. Headquartered in Van Nuys, California, Unicare operates as a family-owned and operated closed-door pharmacy. It provides... Read Story

August 11, 2017, 08:00 AM

Ashland Global Holdings Inc. announced that its indirect, wholly owned subsidiary, Ashland LLC is seeking to obtain a new $600 million 7-year senior secured term loan B facility to retire the company's 3.875% senior notes due 2018.In addition, the... Read Story

May 16, 2017, 08:00 AM

Square 1 Bank, a division of Pacific Western Bank, announced that it has provided a $4 million credit facility to new client Recursion Pharmaceuticals, Inc., a leading pharmaceutical discovery company. Proceeds from the facility will be used to... Read Story

February 08, 2017, 07:22 AM

Deloitte Corporate Finance LLC acted as financial advisor to Houston-based Advanced Pharma, Inc. (Advanced Pharma) on its sale to Avella Specialty Pharmacy (Avella). Advanced Pharma is an FDA-registered 503B Outsourcing Facility providing compounded... Read Story

February 06, 2017, 08:00 AM

Parnell Pharmaceuticals Holdings Ltd, a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, announced that it has entered into a $20 million, senior secured... Read Story

November 23, 2016, 07:31 AM

aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, announced it has entered into a $20 million credit facility with Silicon Valley Bank (SVB) and... Read Story

November 22, 2016, 07:08 AM

Valeant Pharmaceuticals International, Inc. announced that it has obtained the requisite lender approval for an amendment to its credit facility.  The company expects to close the amendment next week, subject to customary closing conditions. The... Read Story

August 22, 2016, 07:28 AM

MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm drug delivery technology to improve patient outcomes and to address unmet needs, announced the closing of a $50 million credit facility with Perceptive Advisors. The proceeds... Read Story

August 19, 2016, 07:27 AM

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced it has entered into a $30 million loan and security agreement with Oxford Finance. Proceeds from the... Read Story

June 20, 2016, 07:52 AM

Maranon Capital, L.P. announced that it provided unitranche financing to support the acquisition of a majority interest in Wedgewood Pharmacy by New Harbor Capital.Wedgewood, headquartered in Swedesboro, NJ, is an industry leading provider of... Read Story

June 10, 2016, 07:36 AM

Omeros Corporation announced that it has entered into an amendment to its existing credit facility with Oxford Finance LLC and East West Bank to provide the company with an additional $20 million in unrestricted cash by funding the remaining tranches... Read Story

May 18, 2016, 07:59 AM

CIT Group announced that CIT Healthcare Finance served as Sole Lead Arranger and Administrative Agent for a $50 million senior secured credit facility to Superior Biologics, a leading home infusion and specialty pharmacy provider offering services to... Read Story

March 08, 2016, 08:01 AM

Mast Therapeutics, Inc., a biopharmaceutical company developing novel, clinical-stage therapies for sickle cell disease and heart failure, announced that it has entered into an amendment to its existing $15 million debt facility with Hercules Capital... Read Story

March 01, 2016, 07:41 AM

Acerus Pharmaceuticals Corporation reported that it has entered into an agreement to amend its senior secured term credit facility with an affiliate of MidCap Financial, LLC.Pursuant to the terms and conditions of this amendment, the company will... Read Story

December 14, 2015, 07:09 AM

Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, announced the closing of a $250.0 million credit facility in connection with the financing of its acquisition of R-Tech Ueno. The loans under the credit facility were fully allocated... Read Story

October 23, 2015, 07:19 AM

Horizon Technology Finance Corporation closed a new $6.3 million venture loan to an existing portfolio company, New Haven Pharmaceuticals, Inc. (“NHP”), a privately held specialty pharmaceuticals company.NHP will use the proceeds of the venture loan... Read Story

October 07, 2015, 07:36 AM

Jaguar Animal Health, Inc., an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, announced it has obtained a senior secured term loan facility for up to $8... Read Story

August 24, 2015, 07:11 AM

Brown Gibbons Lang & Company (BGL) announced the sale of Celsis International Ltd. (Celsis) to Charles River Laboratories International, Inc. for $212 million in cash. BGL's Healthcare & Life Sciences team served as the exclusive financial advisor to... Read Story

July 28, 2015, 07:17 AM

Sarepta Therapeutics, Inc., a developer of innovative RNA-targeted therapeutics, entered into a credit and security agreement with MidCap Financial, a middle market-focused, specialty finance firm, that establishes a senior secured term loan facility... Read Story

June 29, 2015, 07:36 AM

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, has entered into a loan agreement with IMMY Funding LLC, an affiliate of Life Sciences Alternative... Read Story

May 13, 2015, 07:32 AM

Lannett Company, Inc. announced that it has amended and increased its five-year revolving credit facility to $120 million from $50 million.  The amended facility includes an accordion feature that will allow the company to increase borrowings by a... Read Story

April 27, 2015, 07:29 AM

Melinta Therapeutics has entered into a $30 million growth capital debt financing agreement with Hercules Technology Growth Capital, Inc. The initial funding of $20 million closed in December 2014. Melinta has the option, under the terms of the... Read Story

February 10, 2015, 07:13 AM

With over 4,500 assets formerly owned by Ameridose about to hit the block, an online-only medical/pharmaceutical auction of impressive proportions is currently taking shape.  This five day event will be taking place online via webcast starting... Read Story

January 28, 2015, 07:18 AM

ADMA Biologics, Inc., a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, announced that it has received a $5... Read Story

December 16, 2014, 07:31 AM

Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced the successful completion on June 23, 2014 of the restructuring proposed to and approved by its... Read Story

July 07, 2014, 07:18 AM

Nanotherapeutics, Inc., an integrated biopharmaceutical company with a focus on advanced development and manufacturing, announced that it has secured a $30 million loan facility from Hercules Technology Growth Capital, Inc. The funds from the loan... Read Story

June 04, 2014, 07:17 AM

Deerfield Management Company announced it has committed to invest up to $60 million in KemPharm, Inc. through a $10 million senior secured convertible note and a $50 million senior secured term debt facility. The facility provides KemPharm with... Read Story

June 04, 2014, 07:12 AM

Relypsa, Inc., a biopharmaceutical company, announced it has secured a loan facility of up to $35 million with Oxford Finance LLC ("Oxford") and Silicon Valley Bank ("SVB").Under the terms of the agreement, the company immediately drew $15 million... Read Story

June 03, 2014, 07:19 AM

Omega Commercial Finance Corporation , the parent company to Capital MatchPointTM, announces their plans to launch an alternative finance division solely focused on the international and domestic legalized cannabis medical marijuana market through a... Read Story

April 08, 2014, 07:26 AM

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced that it has closed a $30 million non-dilutive loan transaction with Oxford Finance LLC (“Oxford”). The loan funds will be... Read Story

March 06, 2014, 08:05 AM

InnoPharma, Inc. announced that it has closed on a $20 million term loan facility, provided by Athyrium Capital Management through its Athyrium Opportunities Fund. Proceeds will support the company's ongoing development of complex generic and... Read Story

November 14, 2013, 07:21 AM

Salix Pharmaceuticals, Ltd. and Santarus, Inc. announced that the companies have entered into a definitive merger agreement under which Salix will acquire all of the outstanding common stock of Santarus for $32.00 per share in cash (without interest)... Read Story

November 08, 2013, 07:25 AM

Furiex Pharmaceuticals, Inc. has executed a $15 million debt financing transaction with Fred Eshelman, Pharm.D., chairman and a 27.5% shareholder of Furiex. In parallel, Furiex has also entered into a Second Amended and Restated Loan and Security... Read Story

October 01, 2013, 07:29 AM

Monroe Capital LLC announced the funding of a $75 million senior secured credit facility to support the growth of Alora Pharmaceuticals, LLC ("Alora"), the parent company of Avion Pharmaceuticals, LLC and Acella Pharmaceuticals, LLC. Based in... Read Story

September 17, 2013, 07:57 AM

US Capital Partners, LLC has provided expansive term loan financing for Chantilly BioPharma, LLC, headquartered in Chantilly, VA. US Capital Partners is a private investment bank that makes direct debt investments, participates in debt facilities... Read Story

August 14, 2013, 07:39 AM

BioDelivery Sciences International, Inc. secured a $20.0 million senior secured loan from an affiliate of MidCap Financial, LLC.The proceeds of the loan strengthens the cash position as BDSI moves toward the submission of a New Drug Application (NDA)... Read Story

July 08, 2013, 08:00 AM